BACKGROUND: Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree. METHODS: A selective literature search with additional scrutiny of guidelines and meta-analyses. RESULTS: The management of patients with BPH is complex. Emptying and retention disorders can be treated by various pharmacological and surgical means. Transurethral resection of the prostate (TURP) has long been considered the gold standard for operative treatment. Transurethral enucleation procedures show a better risk profile in some uses, however, and have, above all, largely displaced suprapubic prostatectomy. Numerous innovative treatment options have been developed in recent years, but their long-term effects remain to be determined. These treatment techniques can nevertheless be used in individual cases after thorough discussion with the patient. CONCLUSION: The care of patients with BPH should be interdisciplinary. The efficacy and safety of many new developments in the area of pharmacological and minimally invasive treatment remain to be demonstrated in randomized trials.
BACKGROUND: Benign prostatic hyperplasia (BPH) is characterized by the occurrence of.disorders of urine storage and bladder emptying. Most men over the age of 60 years are affected to some degree. METHODS: A selective literature search with additional scrutiny of guidelines and meta-analyses. RESULTS: The management of patients with BPH is complex. Emptying and retention disorders can be treated by various pharmacological and surgical means. Transurethral resection of the prostate (TURP) has long been considered the gold standard for operative treatment. Transurethral enucleation procedures show a better risk profile in some uses, however, and have, above all, largely displaced suprapubic prostatectomy. Numerous innovative treatment options have been developed in recent years, but their long-term effects remain to be determined. These treatment techniques can nevertheless be used in individual cases after thorough discussion with the patient. CONCLUSION: The care of patients with BPH should be interdisciplinary. The efficacy and safety of many new developments in the area of pharmacological and minimally invasive treatment remain to be demonstrated in randomized trials.
Authors: Rodrigo Suarez-Ibarrola; Thorsten Bach; Simon Hein; Andrea Cocci; Giorgio Ivan Russo; Thomas R W Herrmann; Christian Gratzke; Arkadiusz Miernik Journal: World J Urol Date: 2019-09-26 Impact factor: 4.226
Authors: Mihir Desai; Mo Bidair; Kevin C Zorn; Andrew Trainer; Andrew Arther; Eugene Kramolowsky; Leo Doumanian; Dean Elterman; Ronald P Kaufman; James Lingeman; Amy Krambeck; Gregg Eure; Gopal Badlani; Mark Plante; Edward Uchio; Greg Gin; Larry Goldenberg; Ryan Paterson; Alan So; Mitch Humphreys; Claus Roehrborn; Steven Kaplan; Jay Motola; Naeem Bhojani Journal: BJU Int Date: 2019-03-29 Impact factor: 5.588
Authors: Claus G Roehrborn; Jack Barkin; Steven N Gange; Neal D Shore; Jonathan L Giddens; Damien M Bolton; Barrett E Cowan; Anthony L Cantwell; Kevin T McVary; Alexis E Te; Shahram S Gholami; William G Moseley; Peter T Chin; William T Dowling; Sheldon J Freedman; Peter F Incze; K Scott Coffield; Sean Herron; Prem Rashid; Daniel B Rukstalis Journal: Can J Urol Date: 2017-06 Impact factor: 1.344
Authors: Mehmet Yilmaz; Mustafa Karaaslan; Halil Cagri Aybal; Maximilian Ferry von Bargen; Senol Tonyali; Tuncay Toprak; Christian Gratzke; Arkadiusz Miernik Journal: Ann Med Surg (Lond) Date: 2022-07-31